Lyka Generics Limited, a active public limited company, was established on 16 March 2013 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85100MH2013PLC241035. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Formerly known as Lyka Animal Healthcare Limited. It upholds a compliant status. Its leadership includes Kunal Narendra Gandhi (Director), Narendra Chimanlal Rathod (Director), Alisha Kunal Gandhi (Director). Past directors included Narendra Chimanlal Rathod, Nehal Gandhi Narendra, Alisha Kunal Gandhi. It holds ₹4.70 Cr open charges and ₹3.68 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6, Floor-Grd, Plot-79, Himalaya House, Ramabai Ambedkar Marg, Crawford Market,, Fort, Mumbai, Maharashtra, 400001.
U85100MH2013PLC241035
241035
16 March 2013
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Lyka Generics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Narendra Gandhi | Director | 16 Mar 2013 | Current |
| Narendra Chimanlal Rathod | Director | 10 Oct 2022 | Current |
| Alisha Kunal Gandhi | Director | 01 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2023 | Past |
| Pramod Abcsdd | Director | 10 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Director | 10 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lyka Generics Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 294.96% increase. The company also saw a substantial improvement in profitability, with a 13962.03% increase in profit. The company's net worth Soared by an impressive increase of 8988.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Lyka Generics had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹47,000,000.00
₹3,682,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2024 | Axis Bank Limited | ₹2.45 Cr | Open |
| 03 Mar 2023 | Axis Bank Limited | ₹2.25 Cr | Open |
| 28 Jan 2020 | Others | ₹3.68 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lyka Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lyka Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lyka Generics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Lyka Generics Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 24.50 M with Charge ID 100936314 was registered on 17 May 2024. was documented.
Lyka Generics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 22.50 M with Charge ID 100693605 was registered on 03 Mar 2023. was recorded as a recent event.
The activity A charge registered on 28 Jan 2020 via Charge ID 100327227 with Others was fully satisfied on 31 Oct 2022. was completed.
Progress on Narendra Chimanlal Rathod was appointed as a Director was appointed as a Director on 10 Oct 2022 & has been associated with this company since 3 years 2 months . was documented.
The CIN of Lyka Generics Limited is U85100MH2013PLC241035.
Lyka Generics Limited is headquartered at 6, Floor-Grd, Plot-79, Himalaya House, Ramabai Ambedkar Marg, Crawford Market,, Fort, Mumbai, Maharashtra, 400001.
Lyka Generics Limited was incorporated on 16 March 2013.
The current directors of Lyka Generics Limited are
The primary industry of Lyka Generics Limited is Trade.
Lyka Generics Limited is unlisted.
The authorized capital of Lyka Generics Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Lyka Generics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX